| Name | Title | Contact Details |
|---|
QualCare, Inc., one of the region`s leading providers of health care coverage, provides the public and private marketplace with a higher-quality, lower-cost alternative to commercial insurance companies. QualCare`s network covers over 100 acute, specialty and rehabilitation hospitals, as well as over 31,000 physicians and other ancillary providers across New Jersey, New York and Pennsylvania. Founded in 1991 from a consortium of hospital systems, QualCare has experienced dramatic growth over the past two decades. Currently, 16 of New Jersey`s largest and most successful hospitals own and serve on QualCare`s Board of Directors. QualCare services over 900,000 members, with a clientele that spans health systems, unions, local governments, school boards, small to large businesses and some of New Jersey`s largest corporations. With rate increases that are consistently below industry standards and unparalleled service satisfaction, QualCare is well positioned to succeed in the changing healthcare industry.
Carolina Medical Electronics is a East Bend, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DRE Medical Inc is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bethesda is a nonprofit Christian organization that provides homes and other services for people with intellectual and developmental disabilities. Bethesda`s over 3,000 dedicated employees, volunteers and direct support professionals provide residential and supported-living services and religious assistance to nearly 2,000 adults with developmental disabilities. For more than 110-years, Bethesda has been devoted to the mission of providing person-centered care and support for people with intellectual and developmental disabilities.
Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalions AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.